Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Duncan

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
The Lancet. Haematology|December 11, 2019
Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statementKris M Mahadeo, Rajinder Bajwa, Hisham Abdel-Azim, et al.
Blood Advances|September 1, 2019
Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and childrenJennifer S Whangbo, Haesook T Kim, Nikola Mirkovic, et al.
Bone Marrow Transplantation|February 21, 2024
Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHDLev Gorfinkel, Sharmila Raghunandan, Benjamin Watkins, et al.
Transplantation and Cellular Therapy|April 7, 2024
The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated ToxicitiesTakuto Takahashi, Benjamin Watkins, Brandi Bratrude, et al.
The New England Journal of Medicine|October 5, 2017
Hematopoietic Stem-Cell Gene Therapy for Cerebral AdrenoleukodystrophyFlorian Eichler, Christine Duncan, Patricia L Musolino, et al.
Blood|June 15, 2023
Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse eventsTakuto Takahashi, Mahmoud Al-Kofahi, Mutaz Jaber, et al.
Blood Advances|December 21, 2023
Intensive care risk and long-term outcomes in pediatric allogeneic hematopoietic cell transplant recipientsMatt S Zinter, Ruta Brazauskas, Joelle Strom, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
Critical Illness Risk and Long-Term Outcomes Following Intensive Care in Pediatric Hematopoietic Cell Transplant RecipientsMatt S Zinter, Ruta Brazauskas, Joelle Strom, et al.
Transplantation and Cellular Therapy|February 27, 2024
International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 UpdateSeth J Rotz, Neel S Bhatt, Betty K Hamilton, et al.
Bone Marrow Transplantation|February 27, 2024
International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 updateSeth J Rotz, Neel S Bhatt, Betty K Hamilton, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
The Lancet. Haematology|December 11, 2019
Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statementKris M Mahadeo, Rajinder Bajwa, Hisham Abdel-Azim, et al.
Blood Advances|September 1, 2019
Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and childrenJennifer S Whangbo, Haesook T Kim, Nikola Mirkovic, et al.
Bone Marrow Transplantation|February 21, 2024
Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHDLev Gorfinkel, Sharmila Raghunandan, Benjamin Watkins, et al.
Transplantation and Cellular Therapy|April 7, 2024
The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated ToxicitiesTakuto Takahashi, Benjamin Watkins, Brandi Bratrude, et al.
The New England Journal of Medicine|October 5, 2017
Hematopoietic Stem-Cell Gene Therapy for Cerebral AdrenoleukodystrophyFlorian Eichler, Christine Duncan, Patricia L Musolino, et al.
Blood|June 15, 2023
Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse eventsTakuto Takahashi, Mahmoud Al-Kofahi, Mutaz Jaber, et al.
Blood Advances|December 21, 2023
Intensive care risk and long-term outcomes in pediatric allogeneic hematopoietic cell transplant recipientsMatt S Zinter, Ruta Brazauskas, Joelle Strom, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
Critical Illness Risk and Long-Term Outcomes Following Intensive Care in Pediatric Hematopoietic Cell Transplant RecipientsMatt S Zinter, Ruta Brazauskas, Joelle Strom, et al.
Transplantation and Cellular Therapy|February 27, 2024
International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 UpdateSeth J Rotz, Neel S Bhatt, Betty K Hamilton, et al.
Bone Marrow Transplantation|February 27, 2024
International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 updateSeth J Rotz, Neel S Bhatt, Betty K Hamilton, et al.
Pageof 5